Adagio Medical Holdings, Inc. 8-K

What Happened

• Adagio Medical Holdings, Inc. (ADGM) filed a Form 8‑K on April 27, 2026 (Item 8.01) to report that it issued a press release titled “Adagio Medical Announces Positive Pivotal Results for vCLAS® Ventricular Ablation System.” The press release is dated April 26, 2026 and is attached to the 8‑K as Exhibit 99.1 and incorporated by reference.

Key Details

• Company: Adagio Medical Holdings, Inc. (ADGM).
• Event: Announced positive pivotal results for the vCLAS® Ventricular Ablation System.
• Filing: Form 8‑K filed April 27, 2026; press release dated April 26, 2026 (Exhibit 99.1).
• Item reported on the Form 8‑K: Item 8.01 (Other Events).

Why It Matters

• A company announcement of positive pivotal results is a material clinical development: pivotal trials are typically the studies that support regulatory submissions and potential commercialization.
• For investors, this news can affect the company’s regulatory pathway, product launch prospects, and long‑term revenue potential tied to the vCLAS system. The 8‑K itself provides the official press release but does not include financial results or timing for regulatory steps—investors should read the attached press release for detailed clinical and next‑step information.